Literature DB >> 29804215

Texture analysis of small renal cell carcinomas at MDCT for predicting relevant histologic and protein biomarkers.

Andrew T Scrima1, Meghan G Lubner2, E Jason Abel3, Thomas C Havighurst4, Daniel D Shapiro3, Wei Huang5, Perry J Pickhardt1.   

Abstract

PURPOSE: To assess CT texture features of small renal cell carcinomas (≤ 4cm) for association with key pathologic features including protein biomarkers.
METHODS: Quantitative CT texture analysis (CTTA) of small renal cancers (≤ 4cm) was performed on non-contrast and portal venous phase abdominal MDCT scans with an ROI drawn at the largest cross-sectional diameter of the tumor using commercially available software. Texture parameters including mean pixel attenuation, the standard deviation (SD) of the pixel distribution histogram, entropy, the mean of positive pixels, the skewness (i.e., asymmetry) of the pixel histogram, kurtosis (i.e., peakness) of the pixel histogram, and the percentage of positive pixels were correlated with pathologic data from surgical resection, including histology and nuclear grade, as well as microarray analysis in a subset (n = 40) including Ki67 index, CRP, and neovascularization (CD105/CD31).
RESULTS: Portal venous phase images were available in 249 patients (105 women, 144 men; mean age, 56.7 years) with tumors ≤ 4cm (mean, median, range, ± SD; 2.66, 2.60, 0.3-4.0 ± 0.85 cm). CT texture features of standard deviation, mean of the positive pixels, and entropy of the pixel histogram were significantly associated with histologic cell type (clear vs. non-clear; p < 0.001). Entropy and mean of the positive pixels also showed an association with nuclear grade, although not statistically significant. In the microarray analysis subset, kurtosis of the pixel histogram was associated with CD105/CD31 (p = 0.05). SD also showed some association with CD 105 positivity (p = 0.02) and CAIX expression (p = 0.01). Non-contrast CT images were available in 174 patients (72 women, 102 men; mean age, 57.5 years). Although the association with histology was not as strong as on the portal venous phase, in the subset of patients with microarray data, SD was found to correlate with CRP (p = 0.08), kurtosis with CRP (p = 0.004), CD105/CD31 (p = 0.002), and with Ki 67 index (p < 0.001).
CONCLUSION: CT texture features were significantly associated with important histopathologic features in small renal cancers. These non-invasive measures can be performed retrospectively and may provide useful information when determining follow-up and treatment of small renal cancers.

Entities:  

Keywords:  CT; CT texture analysis; Protein expression; Small renal mass

Year:  2019        PMID: 29804215     DOI: 10.1007/s00261-018-1649-2

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  5 in total

1.  Predicting aggressive behavior in small renal tumors prior to treatment.

Authors:  Daniel D Shapiro; E Jason Abel
Journal:  Ann Transl Med       Date:  2018-12

Review 2.  Radiomics: an Introductory Guide to What It May Foretell.

Authors:  Stephanie Nougaret; Hichem Tibermacine; Marion Tardieu; Evis Sala
Journal:  Curr Oncol Rep       Date:  2019-06-25       Impact factor: 5.075

3.  Accuracy of CT texture analysis for differentiating low-grade and high-grade renal cell carcinoma: systematic review and meta-analysis.

Authors:  Wei Yu; Gao Liang; Lichuan Zeng; Yang Yang; Yinghua Wu
Journal:  BMJ Open       Date:  2021-12-22       Impact factor: 2.692

4.  A CT-Based Radiomics Nomogram Integrated With Clinic-Radiological Features for Preoperatively Predicting WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma.

Authors:  Yingjie Xv; Fajin Lv; Haoming Guo; Zhaojun Liu; Di Luo; Jing Liu; Xin Gou; Weiyang He; Mingzhao Xiao; Yineng Zheng
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

5.  A Computed Tomography-Based Radiomics Nomogram to Preoperatively Predict Tumor Necrosis in Patients With Clear Cell Renal Cell Carcinoma.

Authors:  Yi Jiang; Wuchao Li; Chencui Huang; Chong Tian; Qi Chen; Xianchun Zeng; Yin Cao; Yi Chen; Yintong Yang; Heng Liu; Yonghua Bo; Chenggong Luo; Yiming Li; Tijiang Zhang; Rongping Wang
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.